Pediatric Dermatology Research Alliance (PeDRA) Annual Conference
小儿皮肤病学研究联盟 (PeDRA) 年会
基本信息
- 批准号:8986128
- 负责人:
- 金额:$ 3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApplications GrantsAreaBasic ScienceBlood VesselsCase StudyChildChild CareChildhoodClinicalClinical ResearchClinical Research ProtocolsClinical TrialsClinical Trials DesignConsensusConsensus DevelopmentCutaneousDermatologicDermatologistDermatologyDiseaseEducational process of instructingExpert OpinionFDA approvedFosteringGeneticGenomicsGoalsGroup MeetingsGuidelinesHealthHereditary DiseaseInflammatoryInheritedInstructionKnowledgeLesionLifeMalignant NeoplasmsMeasuresMethodsModelingMulticenter StudiesNatural HistoryNeonatalOutcomeOutputPatient advocacyPatientsPerformancePharmaceutical PreparationsPhysiciansPremature InfantProcessResearchResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelResearch PriorityScientistSkinStagingStrategic PlanningSupport GroupsSystemic TherapyTechniquesTechnologyTherapeuticTherapeutic InterventionTimeTranslational ResearchTranslationsTreatment ProtocolsUpdateVisionVitiligoWorkadvocacy organizationsbaseclinical carecohortcomparative effectivenessdata managementdesigndrug developmenteffective interventionimprovedinnovationknowledge baselecturesmalformationmeetingsnovelorganizational structurepatient advocacy grouppostersprematurepreventpublic health relevancerepositoryresponseskillsskin disordersymposiumtherapy outcometumorworking group
项目摘要
DESCRIPTION (provided by applicant): Pediatric dermatologists care for children with a broad range of rare and common disorders, such as severe inflammatory skin diseases that require systemic therapy, disfiguring vascular birthmarks, and genetic skin disorders and cutaneous tumors that can be life-endangering. There is a paucity of FDA-approved therapies for these severe conditions and a great need for standardized treatment protocols and methods to measure response. The Pediatric Dermatology Research Alliance (PeDRA) was established to address this therapeutic shortfall. PeDRA's vision is to create and sustain collaborative research networks that conduct well- designed, high-quality multicenter studies to better understand, prevent, treat and cure dermatologic diseases in children. The PeDRA Annual Conference is central to achieving these goals and includes didactic lectures, interactive discussions led by experts in research methodology, panel and poster sessions, and disease-focused small-group meetings. The specific aims are: 1) To provide new and established PeDRA investigators with an essential knowledge base and infrastructure to conduct high-quality multicenter research in pediatric skin disorders; 2) To identify and prioritize the clinica needs and therapeutic opportunities in five specific areas of pediatric dermatology: inflammatory skin diseases, birthmarks, genetic skin disorders, premature and term neonatal skin, and cutaneous malignancies and precursor lesions; and 3) To enhance opportunities for translational research initiatives and innovative therapeutic approaches by facilitating idea-sharing and dialogue between basic scientists, physician investigators, and clinicians.
描述(由申请人提供):儿科皮肤科医生护理患有各种罕见和常见疾病的儿童,例如需要全身治疗的严重炎症性皮肤病、毁容的血管胎记以及可能危及生命的遗传性皮肤病和皮肤肿瘤FDA 批准的针对这些严重疾病的治疗方法很少,因此非常需要标准化的治疗方案和测量反应的方法来解决这一问题。 PeDRA 的愿景是建立和维持合作研究网络,开展精心设计的高质量多中心研究,以更好地了解、预防、治疗和治愈儿童皮肤病。 PeDRA 年会是实现这些目标的核心。包括教学讲座、由研究方法专家主导的互动讨论、小组会议和海报会议以及以疾病为重点的小组会议。具体目标是: 1) 为新的和已建立的 PeDRA 研究人员提供必要的知识库和基础设施来开展研究。儿科皮肤病的高质量多中心研究;2) 确定并优先考虑儿科皮肤病学五个特定领域的临床需求和治疗机会:炎症性皮肤病、胎记、遗传性皮肤病、早产儿和足月新生儿皮肤病以及皮肤恶性肿瘤和3) 通过促进基础科学家、医师研究人员和超级明星之间的思想共享和对话,增加转化研究计划和创新治疗方法的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Lee Bruckner其他文献
Anna Lee Bruckner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Lee Bruckner', 18)}}的其他基金
Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device
使用皮肤喷雾装置治疗隐性营养不良性大疱性表皮松解症的 iPS 细胞疗法的安全性、耐受性和有效性研究
- 批准号:
10721324 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Pediatric Dermatology Research Alliance (PeDRA) Annual Conference
小儿皮肤病学研究联盟 (PeDRA) 年会
- 批准号:
9398306 - 财政年份:2017
- 资助金额:
$ 3万 - 项目类别:
Pediatric Dermatology Research Alliance (PeDRA) Annual Conference
小儿皮肤病学研究联盟 (PeDRA) 年会
- 批准号:
9762587 - 财政年份:2017
- 资助金额:
$ 3万 - 项目类别:
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
西地那非治疗淋巴管畸形的 2 期研究
- 批准号:
9446776 - 财政年份:2014
- 资助金额:
$ 3万 - 项目类别:
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
西地那非治疗淋巴管畸形的 2 期研究
- 批准号:
8612453 - 财政年份:2014
- 资助金额:
$ 3万 - 项目类别:
相似国自然基金
战略研究类:大气学科国家自然科学基金资助布局及其动态变化分析—以2020版申请代码为视角
- 批准号:
- 批准年份:2021
- 资助金额:33 万元
- 项目类别:专项基金项目
中国数学会2009年年会资助申请
- 批准号:10926004
- 批准年份:2009
- 资助金额:15.0 万元
- 项目类别:数学天元基金项目
中药学基础研究现状、资助格局与申请代码的研究
- 批准号:30945203
- 批准年份:2009
- 资助金额:9.0 万元
- 项目类别:专项基金项目
肿瘤学基础研究现状、资助格局与申请代码的研究
- 批准号:30945201
- 批准年份:2009
- 资助金额:8.0 万元
- 项目类别:专项基金项目
模糊数学与系统国际学术研讨会资助申请
- 批准号:10826022
- 批准年份:2008
- 资助金额:4.0 万元
- 项目类别:数学天元基金项目
相似海外基金
Ion Mobility Spectrometry- quadrupole Time-of-Flight (IMS-qToF) Mass Spectrometer
离子淌度光谱仪 - 四极杆飞行时间 (IMS-qToF) 质谱仪
- 批准号:
10630627 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别: